Nardin, E H <br/><br/>
Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes.  [electronic resource] 

 -  The Journal of infectious diseases  Nov 2000 
 - 1486-96 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1086/315871  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Antibodies, Protozoan--biosynthesis<br/>Cohort Studies<br/>Female<br/>Genotype<br/>HLA-DQ Antigens--genetics<br/>HLA-DQ beta-Chains<br/>HLA-DR Antigens--genetics<br/>HLA-DRB1 Chains<br/>Humans<br/>Malaria Vaccines--immunology<br/>Male<br/>Plasmodium falciparum--immunology<br/>Saponins--pharmacology<br/>Vaccines, Synthetic--immunology